The effect of essential medicines programme on rational use of medicines in China

Health Policy and Planning

Volumn 31, Issue 1, 2016, Pages 21-27

  Gong, Yanhong ^a   Yang, Chen ^a   Yin, Xiaoxv ^a   Zhu, Minmin ^b   Yang, Huajie ^a   Wang, Yunxia ^a   Li, Yongbin ^a   Liu, Liqun ^c   Dong, Xiaoxin ^a   Cao, Shiyi ^a   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shenzhen Nanshan Center for Chronic Disease Control   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

China; essential medicines programme; prescribing; primary care; rational use of medicines

Indexed keywords

ESSENTIAL DRUG;

CHINA; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FACTUAL DATABASE; HUMAN; PRESCRIPTION; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; TRENDS;

CHINA; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUGS, ESSENTIAL; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE;

EID: 84966283986     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czv008     Document Type: Article

References (38)

1. Babiarz KS, Miller G, Yi H, Zhang L, Rozelle S. 2010. New evidence on the impact of China's New Rural Cooperative Medical Scheme and its implications for rural primary healthcare: multivariate difference-in-difference analysis. British Medical Journal 341: c5617.
2. Chaudhury RR, Parameswar R, Gupta U et al. 2005. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy Plan 20: 124-136.
3. Chen Z. 2009. Launch of the health-care reform plan in China. Lancet 373: 1322-1324.
4. Chen M, Wang L, Chen W et al. 2013. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program. Pharmacoeconomics 32: 245-255.
5. China Food and Drug Administration. 2008. The primary target of National Essential Medicines Policy. http://www. sda. gov. cn/WS01/CL0446/ 28068. html, accessed 9 December 2013.
6. Chinese Ministry of Health. 2007. Measures for the administration of prescriptions. http://www. moh. gov. cn/fzs/s3576/200804/1f2a754594e84 19e9e164fedcae05f1c. shtml, accessed 9 December 2013.
7. Chinese Ministry of Health. 2009. Implementation of the National Essential Medicines Policy. http://www. moh. gov. cn/mohywzc/s3585/200908/ 42498. shtml, accessed 9 December 2013.
8. Dong L, Wang D, Gao J, Yan H. 2011. Doctor's injection prescribing and its correlates in village health clinics across 10 Provinces of Western China. Journal of Public Health 33: 565-570.
9. Dong L, Yan H, Wang D. 2008. Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. Journal of Antimicrobial Chemotherapy 62: 410-415.
10. Imbens GW, Wooldridge JM. 2009. Recent developments in the econometrics of program evaluation. Journal of Economic Literature 47: 86.
11. Guan X, Liang H, Xue Y et al. 2011. An analysis of China's national essential medicines policy. Journal of Public Health Policy 32: 305-319.
12. Hogerzeil HV, Walker GJ, Sallami AO et al. 1989. Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1: 141-142.
13. Hu S., Financing, Pricing and Utilisation of Pharmaceuticals in China: The Road to Reform [Online Text] 2010, Washington DC: The World Bank.
14. Hu S. 2010. Financing, Pricing and Utilisation of Pharmaceuticals in China: The Road to Reform [online text]. Washington DC: The World Bank. Hu S. 2013. Essential medicine policy in China: pros and cons. Journal of Medical Economics 16: 289-294.
15. Jiang Q, Yu BN, Ying G et al. 2012. Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Services Research 12: 324.
16. le Grand A, Hogerzeil HV, Haaijer-Ruskamp FM. 1999. Intervention research in rational use of drugs: A review. Health Policy Plan 14: 89-102.
17. Li Y, Xu J, Wang F et al. 2012. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs 31: 1075-1082.
18. Li Y, Ying C, Sufang G et al. 2013. Evaluation, in three provinces, of the introduction and impact of China's National Essential Medicines Scheme. Bulletin of theWorld Health Organization 91: 184-194.
19. Murakami H, Kobayashi M, Zhu X et al. 2003. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Social Science&Medicine 57: 1821-1832.
20. Ratanawijitrasin S, Soumerai SB, Weerasuriya K. 2001. Do national medicinal drug policies and essential drug programs improve drug use?: A review of experiences in developing countries. Social Science&Medicine 53: 831-844.
21. Reynolds L, McKee M. 2009. Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy 90: 32-36.
22. Reynolds L, McKee M. 2011. Serve the people or close the sale? Profit-driven overuse of injections and infusions in China's market-based healthcare system. The International Journal of Health Planning andManagement 26: 449-470.
23. Ross-Degnan D, Laing R, Quick J et al. 1992. A strategy for promoting improved pharmaceutical use: The International Network for Rational Use of Drugs. Social Science&Medicine 35: 1329-1341.
24. Ross-Degnan D, Quick J, Laing R, Mabadeje A. 1997. The development of standard values for the WHO drug use prescribing indicators. Social Science &Medicine 35:1329-1341.
25. Roumie CL, Halasa NB, Grijalva CG et al. 2005. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. Journal of General Internal Medicine 20: 697-702.
26. Seiter A, Wang H, Zhang S. 2010. A Generic Drug Policy as a Cornerstone to Essential Medicines in China [online text]. Washington DC: The World Bank.
27. Song Y, Bian Y. 2012. Does national essential medicine system improve rational drug use in primary health care facilities? An empirical study in rural China. Value Health 15: A613.
28. Tu X. 2013. Medicine Utilization of Outpatient in a Tertiary Level Hospitals in Wuhan City [online text]. Wuhan: Huazhong University of Science and Technology.
29. Wang W, Ban X, Liu Z, Jiang L. 2006. Investigation on knowledge about rational drug use in 2419 inpatients. China Pharmacy 17: 471-473.
30. WHO. 1993. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators (DAP Research Series No. 7. WHO/DAP/93. 1). World Heath Organization edition. Geneva: WHO Press.
31. WHO. 2001. How to Develop and Implement a National Drug Policy. 2nd edn. Malta: World Health Organization.
32. WHO. 2006. Using indicators to measure country pharmaceutical situations: fact book on WHO Level I and Level II monitoring indicators. http:// www. who. int/medicines/publications/WHOTCM2006. 2A. pdf, accessed 9 December 2013.
33. WHO. 2009. Medicines Use in Primary Care in Developing and Transitional Countries: Fact Book Summarizing Results from Studies Reported between 1990 and 2006. Geneva: World Health Organization.
34. WHO. 2011. The World Medicince Situation 2011. http://apps. who. int/medi cinedocs/documents/s18064en/s18064en. pdf, accessed 9 December 2013.
35. Yang G, Wang Y, Zeng Y et al. 2013. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381: 1987-2015.
36. Yang L, Liu C, Ferrier JA, Zhou W, Zhang X. 2012. The impact of the national essential medicines policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy and Planning 28: 1-11.
37. Yin X, Song F, Gong Yet al. 2013. A systematic review of antibiotic utilization in China. Journal of Antimicrobial Chemotherapy 68: 2445-2452
38. Yip W, Eggleston K. 2001. Provider payment reform in China: The case of hospital reimbursement in Hainan province. Health Economics 10: 325-339.